DeepMed Research

Alliance for Clinical Trials in Oncology

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2011-01-01

Employees: 251

Market Cap: -

Website: https://www.allianceforclinicaltrialsinoncology.org

Clinical Trials

Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer

Completed

Conditions: Lung Cancer
Nausea and Vomiting
Breast Cancer

Interventions: Procedure: assessment of therapy complications
Procedure: quality-of-life assessment

First Posted Date: 2006-12-28

Last Posted Date: 2016-06-29

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 99

Registration Number: NCT00416689

Assessing Older Patients With Cancer

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Behavioral: quality of life questionnaires

First Posted Date: 2006-12-28

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 93

Registration Number: NCT00416481

Locations: 🇺🇸
Elkhart General Hospital, Elkhart, Indiana, United States
🇺🇸
Memorial Hospital of South Bend, South Bend, Indiana, United States
🇺🇸
Saint Joseph Regional Medical Center, South Bend, Indiana, United States

and more 10 locations

Collection of Patient-Reported Symptoms and Performance Status Via the Internet

Not Applicable

Completed

Conditions: Breast Cancer
Colorectal Cancer
Multiple Myeloma
Prostate Cancer
Lung Cancer
Leukemia

Interventions: Other: internet-based intervention
Other: assessment of therapy complications
Other: Questionnaire Administration

First Posted Date: 2006-12-28

Last Posted Date: 2017-06-27

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 325

Registration Number: NCT00417040

Locations: 🇺🇸
El Camino Hospital Cancer Center, Mountain View, California, United States
🇺🇸
Memorial Hospital of South Bend, South Bend, Indiana, United States
🇺🇸
Heartland Regional Medical Center, Saint Joseph, Missouri, United States

and more 92 locations

Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Phase 2

Completed

Conditions: Melanoma (Skin)

Interventions: Drug: carboplatin
Drug: paclitaxel albumin-stabilized nanoparticle formulation

First Posted Date: 2006-11-28

Last Posted Date: 2018-10-16

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 76

Registration Number: NCT00404235

Locations: 🇺🇸
BroMenn Regional Medical Center, Normal, Illinois, United States
🇺🇸
Oncology Hematology Associates of Central Illinois, PC - Ottawa, Ottawa, Illinois, United States
🇺🇸
Rush-Copley Cancer Care Center, Aurora, Illinois, United States

and more 148 locations

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Phase 2

Completed

Conditions: Esophageal Cancer

Interventions: Biological: cetuximab
Drug: ECF
Drug: IC
Drug: FOLFOX

First Posted Date: 2006-09-28

Last Posted Date: 2021-09-29

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 245

Registration Number: NCT00381706

Locations: 🇺🇸
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States
🇺🇸
Graham Hospital, Canton, Illinois, United States

and more 223 locations

Methylphenidate in Treating Patients With Fatigue Caused by Cancer

Phase 3

Completed

Conditions: Fatigue
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Other: placebo
Drug: methylphenidate hydrochloride

First Posted Date: 2006-09-15

Last Posted Date: 2016-08-01

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 148

Registration Number: NCT00376675

Locations: 🇺🇸
Riverside Methodist Hospital Cancer Care, Columbus, Ohio, United States
🇺🇸
Grant Medical Center Cancer Care, Columbus, Ohio, United States
🇺🇸
Mount Carmel Health - West Hospital, Columbus, Ohio, United States

and more 232 locations

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Phase 3

Completed

Conditions: Cognitive/Functional Effects
Metastatic Cancer
Breast Cancer
Lung Cancer
Prostate Cancer

Interventions: Radiation: stereotactic radiosurgery
Radiation: radiation therapy

First Posted Date: 2006-09-15

Last Posted Date: 2022-09-16

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 213

Registration Number: NCT00377156

Locations: 🇺🇸
Arizona Oncology Services Foundation, Scottsdale, Arizona, United States
🇺🇸
Kaiser Permanente - Division of Research - Oakland, Oakland, California, United States
🇺🇸
Memorial Medical Center, Modesto, California, United States

and more 61 locations

Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection

Phase 3

Completed

Conditions: Lymphedema

Interventions: Other: quality of life assessment
Other: educational intervention
Procedure: Physical therapy

First Posted Date: 2006-09-15

Last Posted Date: 2019-02-07

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 568

Registration Number: NCT00376597

Locations: 🇺🇸
Highland General Hospital, Oakland, California, United States
🇺🇸
Valley Medical Oncology, Fremont, California, United States
🇺🇸
Cancer Center of Kansas, PA - Medical Arts Tower, Wichita, Kansas, United States

and more 71 locations

Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer

Phase 3

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Neurotoxicity

Interventions: Other: placebo
Dietary Supplement: vitamin E

First Posted Date: 2006-08-15

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 207

Registration Number: NCT00363129

Locations: 🇺🇸
Graham Hospital, Canton, Illinois, United States
🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸
Memorial Hospital, Carthage, Illinois, United States

and more 66 locations

Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer

Phase 3

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Dermatologic Complications

Interventions: Drug: sunscreen
Other: placebo

First Posted Date: 2006-08-15

Last Posted Date: 2016-12-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 116

Registration Number: NCT00362986

Locations: 🇺🇸
Genesys Hurley Cancer Institute, Flint, Michigan, United States
🇺🇸
Hurley Medical Center, Flint, Michigan, United States
🇺🇸
St. John Macomb Hospital, Warren, Michigan, United States

and more 202 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy